{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:20:07Z","timestamp":1791188407075,"version":"4.1.0"},"reference-count":212,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2002,2,1]],"date-time":"2002-02-01T00:00:00Z","timestamp":1012521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)"],"published-print":{"date-parts":[[2002,2]]},"DOI":"10.1054\/plef.2001.0341","type":"journal-article","created":{"date-parts":[[2002,9,19]],"date-time":"2002-09-19T15:33:28Z","timestamp":1032449608000},"page":"101-121","source":"Crossref","is-referenced-by-count":456,"title":["Cannabinoid receptors and their ligands"],"prefix":"10.1054","volume":"66","author":[{"given":"R.G.","family":"Pertwee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1054\/plef.2001.0341_RF1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1054\/plef.2001.0341_RF2","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/365061a0","article-title":"Molecular characterization of a peripheral receptor for cannabinoids","volume":"365","author":"Munro","year":"1993","journal-title":"Nature"},{"key":"10.1054\/plef.2001.0341_RF3","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1054\/plef.2001.0341_RF4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00649-9","article-title":"Endocannabinoids","volume":"359","author":"Mechoulam","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF5","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","article-title":"Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action","volume":"21","author":"Di Marzo","year":"1998","journal-title":"Trends Neurosci"},{"key":"10.1054\/plef.2001.0341_RF6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0009-3084(00)00189-4","article-title":"2-arachidonoylglycerol and the cannabinoid receptors","volume":"108","author":"Sugiura","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1054\/plef.2001.0341_RF7","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.061029898","article-title":"2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor","volume":"98","author":"Hanus","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/plef.2001.0341_RF8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2174\/0929867306666220401124036","article-title":"Pharmacology of cannabinoid receptor ligands","volume":"6","author":"Pertwee","year":"1999","journal-title":"Curr Med Chem"},{"key":"10.1054\/plef.2001.0341_RF9","first-page":"1045","article-title":"Endocannabinoid 2-arachidonyl glycerol is a full agonist through human type 2 cannabinoid receptor: antagonism by anandamide","volume":"57","author":"Gonsiorek","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF10","doi-asserted-by":"crossref","first-page":"32 332","DOI":"10.1074\/jbc.273.48.32332","article-title":"Anandamide hydrolysis by human cells in culture and brain","volume":"273","author":"Maccarrone","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1054\/plef.2001.0341_RF11","doi-asserted-by":"crossref","first-page":"5802","DOI":"10.1073\/pnas.96.10.5802","article-title":"Structural determinants for recognition and translocation by the anandamide transporter","volume":"96","author":"Piomelli","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/plef.2001.0341_RF12","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0024-3205(99)00287-8","article-title":"Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators","volume":"65","author":"Di Marzo","year":"1999","journal-title":"Life Sci"},{"key":"10.1054\/plef.2001.0341_RF13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0009-3084(00)00191-2","article-title":"The movement of N -arachidonoylethanolamine (anandamide) across cellular membranes","volume":"108","author":"Hillard","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1054\/plef.2001.0341_RF14","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0009-3084(00)00190-0","article-title":"The fatty acid amide hydrolase (FAAH)","volume":"108","author":"Ueda","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1054\/plef.2001.0341_RF15","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0024-3205(99)00283-0","article-title":"Structure-activity relationships of anandamide, an endogenous cannabinoid ligand","volume":"65","author":"Khanolkar","year":"1999","journal-title":"Life Sci"},{"key":"10.1054\/plef.2001.0341_RF16","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0163-7258(97)82001-3","article-title":"Pharmacology of cannabinoid CB1 and CB2 receptors","volume":"74","author":"Pertwee","year":"1997","journal-title":"Pharmacol Ther"},{"key":"10.1054\/plef.2001.0341_RF17","first-page":"125","article-title":"Advances in cannabinoid receptor pharmacology","author":"Pertwee","year":"1998"},{"key":"10.1054\/plef.2001.0341_RF18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0301-0082(00)00031-9","article-title":"Cannabinoid receptors and pain","volume":"63","author":"Pertwee","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1054\/plef.2001.0341_RF19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0009-3084(00)00187-0","article-title":"Cellular signal transduction by anandamide and 2-arachidonoylglycerol","volume":"108","author":"Howlett","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1054\/plef.2001.0341_RF20","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1523\/JNEUROSCI.19-20-08765.1999","article-title":"Cannabinoids enhance NMDA-elicited Ca2+ signals in cerebellar granule neurons in culture","volume":"19","author":"Netzeband","year":"1999","journal-title":"J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF21","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1093\/oxfordjournals.jbchem.a021838","article-title":"Is the cannabinoid CB1 receptor a 2-arachidonoylglycerol receptor? Structural requirements for triggering a Ca2+ transient in NG108-15 cells","volume":"122","author":"Sugiura","year":"1997","journal-title":"J Biochem"},{"key":"10.1054\/plef.2001.0341_RF22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/bbrc.1996.1757","article-title":"2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells","volume":"229","author":"Sugiura","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1054\/plef.2001.0341_RF23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1469-7793.2001.0095j.x","article-title":"Signal transduction of cannabinoid CB1 receptors in a smooth muscle cell line","volume":"531","author":"Begg","year":"2001","journal-title":"J Physiol"},{"key":"10.1054\/plef.2001.0341_RF24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1124\/mol.59.5.955","article-title":"The CB1 cannabinoid receptor of astrocytes is coupled to sphingomyelin hydrolysis through the adaptor protein FAN","volume":"59","author":"S\u00e1nchez","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-6147(00)01586-8","article-title":"Ceramide: a new second messenger of cannabinoid action","volume":"22","author":"Guzm\u00e1n","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"10.1054\/plef.2001.0341_RF26","first-page":"363","article-title":"Coupling of the expressed cannabinoid CB1 and CB2 receptors to phospholipase C and G protein-coupled inwardly rectifying K+ channels","volume":"6","author":"Ho","year":"1999","journal-title":"Receptors Channels"},{"key":"10.1054\/plef.2001.0341_RF27","first-page":"618","article-title":"Cannabinoid receptors can activate and inhibit G protein-coupled inwardly rectifying potassium channels in aXenopus oocyte expression system","volume":"291","author":"McAllister","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/plef.2001.0341_RF28","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1523\/JNEUROSCI.17-14-05327.1997","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor","volume":"17","author":"Glass","year":"1997","journal-title":"J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF29","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0014-2999(99)00349-0","article-title":"Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor","volume":"374","author":"Calandra","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF30","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1152\/jn.2000.84.5.2356","article-title":"Cannabinoid and kappa opioid receptors reduce potassium K current via activation of Gs proteins in cultured hippocampal neurons","volume":"84","author":"Hampson","year":"2000","journal-title":"J Neurophysiol"},{"key":"10.1054\/plef.2001.0341_RF31","first-page":"884","article-title":"Dual activation and inhibition of adenylyl cyclase by cannabinoid receptor agonists: evidence for agonist-specific trafficking of intracellular responses","volume":"287","author":"Bonhaus","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/plef.2001.0341_RF32","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1038\/sj.bjp.0701101","article-title":"Paradoxical action of the cannabinoid WIN 55,212\u20132 in stimulated and basal cyclic AMP accumulation in rat globus pallidus slices","volume":"120","author":"Maneuf","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0006-8993(97)01195-5","article-title":"The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons","volume":"783","author":"Shen","year":"1998","journal-title":"Brain Res"},{"key":"10.1054\/plef.2001.0341_RF34","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1152\/jn.1999.82.3.1286","article-title":"Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons","volume":"82","author":"Sullivan","year":"1999","journal-title":"J Neurophysiol"},{"key":"10.1054\/plef.2001.0341_RF35","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1469-7793.2001.0731e.x","article-title":"Presynaptic mechanisms underlying cannabinoid inhibition of excitatory synaptic transmission in rat striatal neurons","volume":"532","author":"Huang","year":"2001","journal-title":"J Physiol"},{"key":"10.1054\/plef.2001.0341_RF36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0306-4522(97)00597-6","article-title":"Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum","volume":"85","author":"Szabo","year":"1998","journal-title":"Neuroscience"},{"key":"10.1054\/plef.2001.0341_RF37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1523\/JNEUROSCI.21-01-00109.2001","article-title":"Localization and mechanisms of action of cannabinoid receptors at the glutamatergic synapses of the mouse nucleus accumbens","volume":"21","author":"Robbe","year":"2001","journal-title":"J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF38","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/0006-2952(94)90134-1","article-title":"Effects of anandamide on cannabinoid receptors in rat brain membranes","volume":"47","author":"Childers","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF39","doi-asserted-by":"crossref","first-page":"22330","DOI":"10.1074\/jbc.272.35.22330","article-title":"A selective inverse agonist for central cannabinoid receptor inhibits mitogen-activated protein kinase activation stimulated by insulin or insulin-like growth factor 1. Evidence for a new model of receptor\/ligand interactions","volume":"272","author":"Bouaboula","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1054\/plef.2001.0341_RF40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/sj.bjp.0701915","article-title":"Evidence for inverse agonism of SR141716A at human recombinant cannabinoid CB1 and CB2 receptors","volume":"124","author":"MacLennan","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF41","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1124\/mol.54.6.1064","article-title":"R 141716A acts as an inverse agonist to increase neuronal voltage-dependent Ca2++ currents by reversal of tonic CB1 cannabinoid receptor activity","volume":"54","author":"Pan","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF42","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bjp.0703094","article-title":"Comparison of novel cannabinoid partial agonists and SR141716A in the guinea-pig small intestine","volume":"129","author":"Coutts","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0014-2999(01)00784-1","article-title":"Inhibitory effects of SR141716A on G-protein activation in rat brain","volume":"414","author":"Sim-Selley","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF44","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/S0014-2999(97)89683-5","article-title":"Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR141716A","volume":"327","author":"Gessa","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF45","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/PL00005093","article-title":"Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus","volume":"356","author":"Schlicker","year":"1997","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(98)00486-5","article-title":"Cannabinoids decrease acetylcholine release in the medial-prefrontal cortex and hippocampus, reversal by SR 141716A","volume":"355","author":"Gessa","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF47","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0014-2999(00)00403-9","article-title":"Cannabinoid CB1 receptor agonists increase rat cortical and hippocampal acetylcholine release in vivo","volume":"401","author":"Acquas","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF48","first-page":"644","article-title":"R 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor","volume":"284","author":"Rinaldi-Carmona","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/plef.2001.0341_RF49","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/sj.bjp.0702351","article-title":"Agonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630","volume":"126","author":"Ross","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF50","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/sj.bjp.0702836","article-title":"Structural determinants of the partial agonist-inverse agonist properties of 6\u2032-azidohex-2\u2032-yne-\u03948-tetrahydrocannabinol at cannabinoid receptors","volume":"128","author":"Ross","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF51","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1471-4159.1998.70010417.x","article-title":"Imaging the brain marijuana receptor: development of a radioligand that binds to cannabinoid CB1 receptors in vivo","volume":"70","author":"Gatley","year":"1998","journal-title":"J Neurochem"},{"key":"10.1054\/plef.2001.0341_RF52","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1038\/35069076","article-title":"Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses","volume":"410","author":"Wilson","year":"2001","journal-title":"Nature"},{"key":"10.1054\/plef.2001.0341_RF53","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/00000542-200105000-00029","article-title":"The cannabinoid agonist WIN55,212-2 suppresses opioid-induced emesis in ferrets","volume":"94","author":"Simoneau","year":"2001","journal-title":"Anesthesiology"},{"key":"10.1054\/plef.2001.0341_RF54","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/1098-2396(20001215)38:4<477::AID-SYN13>3.0.CO;2-Y","article-title":"Locomotor activity and occupancy of brain cannabinoid CB1 receptors by the antagonist\/inverse agonist AM281","volume":"38","author":"Cosenza","year":"2000","journal-title":"Synapse"},{"key":"10.1054\/plef.2001.0341_RF55","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S0304-3940(97)00851-3","article-title":"Effect of the cannabinoid receptor SPECT agent, AM 281, on hippocampal acetylcholine release from rat brain slices","volume":"238","author":"Gifford","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1054\/plef.2001.0341_RF56","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/sj.bjp.0703116","article-title":"Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea-pig ileum","volume":"129","author":"Izzo","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF57","doi-asserted-by":"crossref","first-page":"U13","DOI":"10.1208\/ps010204","article-title":"Design and synthesis of the CB1 selective cannabinoid antagonist AM281: a potential human SPECT ligand","volume":"1","author":"Lan","year":"1999","journal-title":"AAPS Pharmsci"},{"key":"10.1054\/plef.2001.0341_RF58","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1517\/13543784.9.7.1553","article-title":"Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development","volume":"9","author":"Pertwee","year":"2000","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1054\/plef.2001.0341_RF59","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1006\/bbrc.2001.4354","article-title":"Highly selective CB1 cannabinoid receptor ligands and novel CB1\/VR1 vanilloid receptor \u2018hybrid\u2019 ligands","volume":"281","author":"Di Marzo","year":"2001","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1054\/plef.2001.0341_RF60","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1046\/j.1471-4159.2000.0742597.x","article-title":"Structure-activity relationships among N-arachidonylethanolamine (anandamide) head group analogues for the anandamide transporter","volume":"74","author":"Jarrahian","year":"2000","journal-title":"J Neurochem"},{"key":"10.1054\/plef.2001.0341_RF61","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2165\/00063030-199912050-00001","article-title":"Effects of cannabinoids on the immune system and central nervous system: therapeutic implications","volume":"12","author":"Molina-Holgado","year":"1999","journal-title":"Biodrugs"},{"key":"10.1054\/plef.2001.0341_RF62","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0009-3084(00)00195-X","article-title":"Cannabinoid receptors and the regulation of immune response","volume":"108","author":"Berdyshev","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1054\/plef.2001.0341_RF63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0006-8993(98)00738-0","article-title":"Inhibition of hippocampal acetylcholine release after acute and repeated \u03949-tetrahydrocannabinol in rats","volume":"809","author":"Carta","year":"1998","journal-title":"Brain Res"},{"key":"10.1054\/plef.2001.0341_RF64","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/sj.bjp.0703413","article-title":"D2 dopamine receptors enable \u03949-tetrahydrocannabinol induced memory impairment and reduction of hippocampal extracellular acetylcholine concentration","volume":"130","author":"Nava","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/0006-8993(96)00533-1","article-title":"Local pressure application of cannabinoid agonists increases spontaneous activity of rat substantia nigra pars reticulata neurons without affecting response to iontophoretically-applied GABA","volume":"733","author":"Tersigni","year":"1996","journal-title":"Brain Res"},{"key":"10.1054\/plef.2001.0341_RF66","first-page":"1431","article-title":"Electrically evoked acetylcholine release from hippocampal slices is inhibited by the cannabinoid receptor agonist, WIN 55212-2, and is potentiated by the cannabinoid antagonist, SR 141716A","volume":"277","author":"Gifford","year":"1996","journal-title":"J Pharmacol Exp. Ther"},{"key":"10.1054\/plef.2001.0341_RF67","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0014-2999(97)00082-4","article-title":"Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices","volume":"324","author":"Gifford","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF68","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0014-2999(99)00609-3","article-title":"Potentiation of the action of anandamide on hippocampal slices by the fatty acid amide hydrolase inhibitor, palmitylsulphonyl fluoride (AM 374)","volume":"383","author":"Gifford","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF69","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/sj.bjp.0703599","article-title":"Cannabinoid receptor-mediated inhibition of acetylcholine release from hippocampal and cortical synaptosomes","volume":"131","author":"Gifford","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s002109900147","article-title":"Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors","volume":"361","author":"Nakazi","year":"2000","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF71","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s002100000304","article-title":"Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL\/6J mice","volume":"363","author":"Kathmann","year":"2001","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF72","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/sj.bjp.0703987","article-title":"Enhanced acetylcholine release in the hippocampus of cannabinoid CB1 receptor-deficient mice","volume":"132","author":"Kathmann","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF73","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/sj.bjp.0701301","article-title":"Inhibition by cannabinoid receptor agonists of acetylcholine release from the guinea-pig myenteric plexus","volume":"121","author":"Coutts","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF74","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjp.0704220","article-title":"Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors","volume":"134","author":"Mang","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF75","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/PL00005377","article-title":"Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain","volume":"359","author":"Kathmann","year":"1999","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF76","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/BF00166907","article-title":"Cannabinoid receptor-mediated inhibition of dopamine release in the retina","volume":"354","author":"Schlicker","year":"1996","journal-title":"Naunyn-Schmiedeberg's Arch Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF77","first-page":"Pharmacol","article-title":"Presynaptic cannabinoid and imidazoline receptors in the human heart and their potential relationship","volume":"360","author":"Molderings","year":"1999","journal-title":"Naunyn-Schmiedeberg's Arch"},{"key":"10.1054\/plef.2001.0341_RF78","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1111\/j.1476-5381.1996.tb15639.x","article-title":"Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves","volume":"118","author":"Ishac","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF79","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.bjp.0703305","article-title":"Modulation of 3H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and\u03b2 -adrenoceptors in mouse tissues","volume":"130","author":"Trendelenburg","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF80","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1471-4159.2000.0752087.x","article-title":"Electrically evoked release of [3H]noradrenaline from mouse cultured sympathetic neurons: release-modulating heteroreceptors","volume":"75","author":"G\u00f6bel","year":"2000","journal-title":"J Neurochem"},{"key":"10.1054\/plef.2001.0341_RF81","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1046\/j.1471-4159.1997.69031131.x","article-title":"Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum","volume":"69","author":"Cadogan","year":"1997","journal-title":"J Neurochem"},{"key":"10.1054\/plef.2001.0341_RF82","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1469-7793.2001.00805.x","article-title":"Cannabinoid actions on rat superficial medullary dorsal horn neurons in vitro","volume":"534","author":"Jennings","year":"2001","journal-title":"J Physiol"},{"key":"10.1054\/plef.2001.0341_RF83","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0306-4522(00)00286-4","article-title":"GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus","volume":"100","author":"Katona","year":"2000","journal-title":"Neuroscience"},{"key":"10.1054\/plef.2001.0341_RF84","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","article-title":"Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons","volume":"19","author":"Katona","year":"1999","journal-title":"J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF85","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1523\/JNEUROSCI.20-07-02470.2000","article-title":"Mechanisms of cannabinoid inhibition of GABAA synaptic transmission in the hippocampus","volume":"20","author":"Hoffman","year":"2000","journal-title":"J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF86","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1046\/j.1460-9568.2000.00217.x","article-title":"Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations","volume":"12","author":"H\u00e1jos","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF87","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0306-4522(00)00120-2","article-title":"Functional expression of cell surface cannabinoid CB1 receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons","volume":"98","author":"Irving","year":"2000","journal-title":"Neuroscience"},{"key":"10.1054\/plef.2001.0341_RF88","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0896-6273(01)00247-1","article-title":"Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals","volume":"29","author":"Ohno-Shosaku","year":"2001","journal-title":"Neuron"},{"key":"10.1054\/plef.2001.0341_RF89","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/00001756-199803090-00020","article-title":"Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist","volume":"9","author":"Chan","year":"1998","journal-title":"Neuroreport"},{"key":"10.1054\/plef.2001.0341_RF90","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3940(98)00396-6","article-title":"Occlusion of the presynaptic action of cannabinoids in rat substantia nigra pars reticulata by cadmium","volume":"249","author":"Chan","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1054\/plef.2001.0341_RF91","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1038\/sj.bjp.0702636","article-title":"Cannabinoid receptor activation inhibits GABAergic neurotransmission in rostral ventromedial medulla neurons in vitro","volume":"127","author":"Vaughan","year":"1999","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF92","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1152\/jn.2000.83.3.1167","article-title":"Cannabinoid receptor modulation of synapses received by cerebellar Purkinje cells","volume":"83","author":"Takahashi","year":"2000","journal-title":"J Neurophysiol"},{"key":"10.1054\/plef.2001.0341_RF93","first-page":"288","article-title":"Actions of cannabinoids on membrane properties and synaptic transmission in rat periaqueductal gray neurons in vitro","volume":"57","author":"Vaughan","year":"2000","journal-title":"Mol Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF94","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1152\/jn.2001.85.1.72","article-title":"Direct actions of cannabinoids on synaptic transmission in the nucleus accumbens: a comparison with opioids","volume":"85","author":"Hoffman","year":"2001","journal-title":"J Neurophysiol"},{"key":"10.1054\/plef.2001.0341_RF95","doi-asserted-by":"crossref","first-page":"R3","DOI":"10.1016\/S0014-2999(01)00723-3","article-title":"Cannabinoids inhibit GABAergic synaptic transmission in mice nucleus accumbens","volume":"412","author":"Manzoni","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF96","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1152\/jn.2000.83.6.3287","article-title":"Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons","volume":"83","author":"Auclair","year":"2000","journal-title":"J Neurophysiol"},{"key":"10.1054\/plef.2001.0341_RF97","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1523\/JNEUROSCI.16-14-04322.1996","article-title":"Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures","volume":"16","author":"Shen","year":"1996","journal-title":"J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF98","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1124\/mol.54.3.459","article-title":"Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity","volume":"54","author":"Shen","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF99","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1124\/mol.55.1.8","article-title":"\u03949-Tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture","volume":"55","author":"Shen","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF100","doi-asserted-by":"crossref","first-page":"6795","DOI":"10.1523\/JNEUROSCI.19-16-06795.1999","article-title":"Mechanism of cannabinoid effects on long-term potentiation and depression in hippocampal CA1 neurons","volume":"19","author":"Misner","year":"1999","journal-title":"J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF101","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/j.1469-7793.1998.867bj.x","article-title":"Cannabinoids decrease excitatory synaptic transmission and impair long-term depression in rat cerebellar Purkinje cells","volume":"510","author":"L\u00e9v\u00e9n\u00e8s","year":"1998","journal-title":"J Physiol"},{"key":"10.1054\/plef.2001.0341_RF102","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/S0896-6273(01)00246-X","article-title":"Retrograde inhibition of presynaptic calcium influx by endogenous cannabinoids at excitatory synapses onto Purkinje cells","volume":"29","author":"Kreitzer","year":"2001","journal-title":"Neuron"},{"key":"10.1054\/plef.2001.0341_RF103","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","article-title":"CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum","volume":"85","author":"Gerdeman","year":"2001","journal-title":"J Neurophysiol"},{"key":"10.1054\/plef.2001.0341_RF104","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0306-4522(00)00036-1","article-title":"Cannabinoids inhibit excitatory neurotransmission in the substantia nigra pars reticulata","volume":"97","author":"Szabo","year":"2000","journal-title":"Neuroscience"},{"key":"10.1054\/plef.2001.0341_RF105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1152\/jn.2001.86.1.40","article-title":"Cannabinoid-induced presynaptic inhibition of glutamatergic EPSCs in substantia gelatinosa neurons of the rat spinal cord","volume":"86","author":"Morisset","year":"2001","journal-title":"J Neurophysiol"},{"key":"10.1054\/plef.2001.0341_RF106","series-title":"2001 Symposium on the Cannabinoids","article-title":"Functional expression of cell surface CB1 receptors at synaptic terminals in cultured cerebellar granule cells","author":"Irving","year":"2001"},{"key":"10.1054\/plef.2001.0341_RF107","series-title":"1999 Symposium on the Cannabinoids","article-title":"Cannabinoid signaling in cultured rat cerebellar granule cells","author":"Breivogel","year":"1999"},{"key":"10.1054\/plef.2001.0341_RF108","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3940(01)01591-9","article-title":"Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids","volume":"301","author":"Beinfeld","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1054\/plef.2001.0341_RF109","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/(SICI)1098-2396(199604)22:4<382::AID-SYN9>3.0.CO;2-7","article-title":"Modulation of GABAergic transmission in the globus pallidus by the synthetic cannabinoid WIN 55,212-2","volume":"22","author":"Maneuf","year":"1996","journal-title":"Synapse"},{"key":"10.1054\/plef.2001.0341_RF110","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0014-2999(96)00326-3","article-title":"Activation of the cannabinoid receptor by \u03949-tetrahydrocannabinol reduces \u03b3-aminobutyric acid uptake in the globus pallidus","volume":"308","author":"Maneuf","year":"1996","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF111","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0024-3205(97)01117-X","article-title":"The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake","volume":"62","author":"Romero","year":"1998","journal-title":"Life Sci"},{"key":"10.1054\/plef.2001.0341_RF112","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/S0028-3908(98)00096-3","article-title":"Correlation between cannabinoid mediated effects on paired pulse depression and induction of long term potentiation in the rat hippocampal slice","volume":"37","author":"Paton","year":"1998","journal-title":"Neuropharmacol"},{"key":"10.1054\/plef.2001.0341_RF113","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF114","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.0.CO;2-K","article-title":"Localization of cannabinoid CB1 receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study","volume":"37","author":"Hohmann","year":"2000","journal-title":"Synapse"},{"key":"10.1054\/plef.2001.0341_RF115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1054\/plef.2001.0341_RF116","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1098\/rspb.1998.0543","article-title":"A new perspective on cannabinoid signalling: complementary localization of fatty acid amide hydrolase and the CB1 receptor in rat brain","volume":"265","author":"Egertov\u00e1","year":"1998","journal-title":"Proc R Soc London B"},{"key":"10.1054\/plef.2001.0341_RF117","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0306-4522(99)00086-X","article-title":"Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation","volume":"93","author":"Tsou","year":"1999","journal-title":"Neuroscience"},{"key":"10.1054\/plef.2001.0341_RF118","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1","article-title":"Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB1","volume":"422","author":"Egertov\u00e1","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1054\/plef.2001.0341_RF119","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1523\/JNEUROSCI.21-03-00823.2001","article-title":"Ultrastructural localization of the CB1 cannabinoid receptor in \u03bc -opioid receptor patches of the rat caudate putamen nucleus","volume":"21","author":"Rodr\u0131\u0301guez","year":"2001","journal-title":"J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF120","series-title":"2001 Symposium on the Cannabinoids","article-title":"Comparison of cannabinoid antibodies in the determination of CB1 receptor distribution in the myenteric plexus","author":"Anavi-Goffer","year":"2001"},{"key":"10.1054\/plef.2001.0341_RF121","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s004410000261","article-title":"Localization of CB1-cannabinoid receptor immunoreactivity in the porcine enteric nervous system","volume":"302","author":"Kulkarni-Narla","year":"2000","journal-title":"Cell Tissue Res"},{"key":"10.1054\/plef.2001.0341_RF122","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02245916","article-title":"\u03949-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis","volume":"102","author":"Chen","year":"1990","journal-title":"Psychopharmacologia"},{"key":"10.1054\/plef.2001.0341_RF123","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0014-2999(90)94136-L","article-title":"\u03949-tetrahydrocannabinol enhances presynaptic dopamine efflux in medial prefrontal cortex","volume":"190","author":"Chen","year":"1990","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF124","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0304-3940(91)90739-G","article-title":"Strain-specific facilitation of dopamine efflux by \u03949-tetrahydrocannabinol in the nucleus accumbens of rat: an in vivo microdialysis study","volume":"129","author":"Chen","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1054\/plef.2001.0341_RF125","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00001756-199702100-00014","article-title":"Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra","volume":"8","author":"French","year":"1997","journal-title":"Neuroreport"},{"key":"10.1054\/plef.2001.0341_RF126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(97)00278-4","article-title":"\u03949-tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors","volume":"226","author":"French","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1054\/plef.2001.0341_RF127","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","article-title":"Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common \u03bc1 opioid receptor mechanism","volume":"276","author":"Tanda","year":"1997","journal-title":"Science"},{"key":"10.1054\/plef.2001.0341_RF128","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(97)01442-8","article-title":"Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors","volume":"341","author":"Gessa","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF129","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0278-5846(00)00119-6","article-title":"Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain","volume":"24","author":"Melis","year":"2000","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatr"},{"key":"10.1054\/plef.2001.0341_RF130","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0306-4522(00)00241-4","article-title":"Lack of response suppression follows repeated ventral tegmental cannabinoid administration: an in vitro electrophysiological study","volume":"99","author":"Cheer","year":"2000","journal-title":"Neuroscience"},{"key":"10.1054\/plef.2001.0341_RF131","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0014-2999(01)00967-0","article-title":"\u03949-tetrahydrocannabinol enhances cortical and hippocampal acetylcholine release in vivo: a microdialysis study","volume":"419","author":"Acquas","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF132","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/cercor\/11.8.728","article-title":"The cannabinoid receptor agonist WIN 55,212-2 regulates glutamate transmission in rat cerebral cortex: an in vivo and in vitro study","volume":"11","author":"Ferraro","year":"2001","journal-title":"Cerebral Cortex"},{"key":"10.1054\/plef.2001.0341_RF133","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"key":"10.1054\/plef.2001.0341_RF134","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"10.1054\/plef.2001.0341_RF135","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1098\/rstb.2000.0787","article-title":"The neurobiology and evolution of cannabinoid signalling","volume":"356","author":"Elphick","year":"2001","journal-title":"Philos Trans R Soc London B"},{"key":"10.1054\/plef.2001.0341_RF136","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(98)00700-9","article-title":"Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry","volume":"254","author":"Tsou","year":"1998","journal-title":"Neurosci Letts"},{"key":"10.1054\/plef.2001.0341_RF137","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/(SICI)1099-0801(200004)14:2<118::AID-BMC936>3.0.CO;2-O","article-title":"Sensitive determination of anandamide in rat brain utilizing a coupled-column HPLC with fluorimetric detection","volume":"14","author":"Arai","year":"2000","journal-title":"Biomed Chromatogr"},{"key":"10.1054\/plef.2001.0341_RF138","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-2999(00)00786-X","article-title":"Elevated circulating levels of anandamide after administration of the transport inhibitor, AM404","volume":"408","author":"Giuffrida","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF139","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/bbrc.2000.2406","article-title":"Sex steroid influence on cannabinoid CB1 receptor mRNA and endocannabinoid levels in the anterior pituitary gland","volume":"270","author":"Gonz\u00e1lez","year":"2000","journal-title":"Biochem Biophys Res Communs"},{"key":"10.1054\/plef.2001.0341_RF140","doi-asserted-by":"crossref","first-page":"12198","DOI":"10.1073\/pnas.96.21.12198","article-title":"Pain modulation by release of the endogenous cannabinoid anandamide","volume":"96","author":"Walker","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/plef.2001.0341_RF141","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/7268","article-title":"Dopamine activation of endogenous cannabinoid signaling in dorsal striatum","volume":"2","author":"Giuffrida","year":"1999","journal-title":"Nature Neurosci"},{"key":"10.1054\/plef.2001.0341_RF142","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1096\/fj.14.10.1432","article-title":"Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson\u2019s disease","volume":"14","author":"Di Marzo","year":"2000","journal-title":"FASEB J"},{"key":"10.1054\/plef.2001.0341_RF143","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1096\/fj.00-0399fje","article-title":"Endocannabinoids control spasticity in a multiple sclerosis model","volume":"15","author":"Baker","year":"2001","journal-title":"FASEB J"},{"key":"10.1054\/plef.2001.0341_RF144","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/35071088","article-title":"Leptin-regulated endocannabinoids are involved in maintaining food intake","volume":"410","author":"Di Marzo","year":"2001","journal-title":"Nature"},{"key":"10.1054\/plef.2001.0341_RF145","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/00001756-200107200-00017","article-title":"Changes in endocannabinoid transmission in the basal ganglia in a rat model of Huntington\u2019s disease","volume":"12","author":"Lastres-Becker","year":"2001","journal-title":"Neuroreport"},{"key":"10.1054\/plef.2001.0341_RF146","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0024-3205(99)00251-9","article-title":"Extrapyramidal and neuroendocrine effects of AM404, an inhibitor of the carrier-mediated transport of anandamide","volume":"65","author":"Gonz\u00e1lez","year":"1999","journal-title":"Life Sci"},{"key":"10.1054\/plef.2001.0341_RF147","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1523\/JNEUROSCI.20-09-03401.2000","article-title":"Reversal of dopamine D2 receptor responses by an anandamide transport inhibitor","volume":"20","author":"Beltramo","year":"2000","journal-title":"J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF148","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-2999(01)01012-3","article-title":"Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues","volume":"420","author":"Di Marzo","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF149","first-page":"1138","article-title":"The effect of the enzyme inhibitor phenylmethylsulfonyl fluoride on the pharmacological effect of anandamide in the mouse model of cannabimimetic activity","volume":"283","author":"Compton","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/plef.2001.0341_RF150","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0014-5793(98)01175-2","article-title":"Interactions between synthetic vanilloids and the endogenous cannabinoid system","volume":"436","author":"Di Marzo","year":"1998","journal-title":"FEBS Lett"},{"key":"10.1054\/plef.2001.0341_RF151","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/22761","article-title":"Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide","volume":"400","author":"Zygmunt","year":"1999","journal-title":"Nature"},{"key":"10.1054\/plef.2001.0341_RF152","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/sj.bjp.0703050","article-title":"The endogenous lipid anandamide is a full agonist at the human vanilloid receptor (hVR1)","volume":"129","author":"Smart","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF153","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bjp.0703850","article-title":"Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens","volume":"132","author":"Ross","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF154","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1523\/JNEUROSCI.21-04-01104.2001","article-title":"Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation","volume":"21","author":"Tognetto","year":"2001","journal-title":"J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF155","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1046\/j.1471-4159.2001.00406.x","article-title":"The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase","volume":"77","author":"De Petrocellis","year":"2001","journal-title":"J Neurochem"},{"key":"10.1054\/plef.2001.0341_RF156","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/35050121","article-title":"Induction of vanilloid receptor channel activity by protein kinase C","volume":"408","author":"Premkumar","year":"2000","journal-title":"Nature"},{"key":"10.1054\/plef.2001.0341_RF157","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/sj.bjp.0703456","article-title":"Vanilloid receptors on capsaicin-sensitive sensory nerves mediate relaxation to methanandamide in the rat isolated mesenteric arterial bed and small mesenteric arteries","volume":"130","author":"Ralevic","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF158","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-2999(01)00940-2","article-title":"Cannabinoid inhibition of capsaicin-sensitive sensory neurotransmission in the rat mesenteric arterial bed","volume":"418","author":"Ralevic","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF159","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0306-4522(00)00389-4","article-title":"Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons","volume":"100","author":"Ahluwalia","year":"2000","journal-title":"Neuroscience"},{"key":"10.1054\/plef.2001.0341_RF160","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.bjp.0703919","article-title":"Cannabinoid inhibition of the capsaicin-induced calcium response in rat dorsal root ganglion neurones","volume":"132","author":"Millns","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF161","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0014-2999(00)00687-7","article-title":"Neurobehavioral activity in mice of N -vanillyl-arachidonyl-amide","volume":"406","author":"Di Marzo","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF162","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0014-5793(00)02082-2","article-title":"Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity","volume":"483","author":"De Petrocellis","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1054\/plef.2001.0341_RF163","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(00)00207-7","article-title":"The anandamide transport inhibitor AM404 activates vanilloid receptors","volume":"396","author":"Zygmunt","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF164","first-page":"73P","article-title":"The anandamide transport inhibitor AM404 is an agonist at the rat vanilloid receptor (VR1)","volume":"129","author":"Jerman","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF165","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1126\/science.277.5329.1094","article-title":"Functional role of high-affinity anandamide transport, as revealed by selective inhibition","volume":"277","author":"Beltramo","year":"1997","journal-title":"Science"},{"key":"10.1054\/plef.2001.0341_RF166","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/28393","article-title":"Control of pain initiation by endogenous cannabinoids","volume":"394","author":"Calignano","year":"1998","journal-title":"Nature"},{"key":"10.1054\/plef.2001.0341_RF167","doi-asserted-by":"crossref","first-page":"7656","DOI":"10.1073\/pnas.90.16.7656","article-title":"Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction","volume":"90","author":"Felder","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/plef.2001.0341_RF168","first-page":"989","article-title":"Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands","volume":"278","author":"Showalter","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/plef.2001.0341_RF169","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1021\/jm960752x","article-title":"Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor","volume":"40","author":"Sheskin","year":"1997","journal-title":"J Med Chem"},{"key":"10.1054\/plef.2001.0341_RF170","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S1388-1981(99)00132-8","article-title":"Analogues and homologues of N-palmitoylethanolamide, a putative endogenous CB2 cannabinoid, as potential ligands for the cannabinoid receptors","volume":"1440","author":"Lambert","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1054\/plef.2001.0341_RF171","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0014-2999(01)00988-8","article-title":"Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide","volume":"419","author":"Calignano","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF172","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0014-2999(97)01336-8","article-title":"Evidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals","volume":"339","author":"Griffin","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF173","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.HYP.33.1.429","article-title":"Mesenteric vasodilation mediated by endothelial anandamide receptors","volume":"33","author":"Wagner","year":"1999","journal-title":"Hypertension"},{"key":"10.1054\/plef.2001.0341_RF174","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors","volume":"96","author":"J\u00e1rai","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/plef.2001.0341_RF175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0009-3084(00)00194-8","article-title":"Endocannabinoids as cardiovascular modulators","volume":"108","author":"Kunos","year":"2000","journal-title":"Chem Phys Lipids"},{"key":"10.1054\/plef.2001.0341_RF176","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1074\/jbc.270.8.3726","article-title":"An amino-terminal variant of the central cannabinoid receptor resulting from alternative splicing","volume":"270","author":"Shire","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1054\/plef.2001.0341_RF177","first-page":"871","article-title":"Characterization of two cloned human CB1 cannabinoid receptor isoforms","volume":"278","author":"Rinaldi-Carmona","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/plef.2001.0341_RF178","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0166-4328(96)00139-8","article-title":"Neurobehavioral effects of \u03949-THC and cannabinoid (CB1) receptor gene expression in mice","volume":"72","author":"Onaivi","year":"1996","journal-title":"Behav Brain Res"},{"key":"10.1054\/plef.2001.0341_RF179","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1471-4892(01)00003-0","article-title":"Orphan G protein-coupled receptors in the CNS","volume":"1","author":"Lee","year":"2001","journal-title":"Curr Opin Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF180","first-page":"1301","article-title":"Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A","volume":"286","author":"Welch","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/plef.2001.0341_RF181","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0006-8993(00)01981-8","article-title":"Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, \u03949-THC and anandamide","volume":"857","author":"Houser","year":"2000","journal-title":"Brain Res"},{"key":"10.1054\/plef.2001.0341_RF182","first-page":"1235","article-title":"Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to \u03949-THC after intrathecal administration to mice: blockade of \u03949-THC-induced antinociception","volume":"273","author":"Welch","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/plef.2001.0341_RF183","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1046\/j.1471-4159.2000.0752434.x","article-title":"Levels, metabolism, and pharmacological activity of anandamide in CB1 cannabinoid receptor knockout mice: evidence for non-CB1, non-CB2 receptor-mediated actions of anandamide in mouse brain","volume":"75","author":"Di Marzo","year":"2000","journal-title":"J Neurochem"},{"key":"10.1054\/plef.2001.0341_RF184","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1124\/mol.60.1.155","article-title":"Evidence for a new G protein-coupled cannabinoid receptor in mouse brain","volume":"60","author":"Breivogel","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF185","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/plef.2001.0341_RF186","series-title":"2001 Symposium on the Cannabinoids","article-title":"Anandamide antagonism: do pharmacokinetics play a role?","author":"Wiley","year":"2001"},{"key":"10.1054\/plef.2001.0341_RF187","first-page":"1209","article-title":"Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain","volume":"284","author":"Adams","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/plef.2001.0341_RF188","first-page":"243","article-title":"The biodisposition and metabolism of anandamide in mice","volume":"282","author":"Willoughby","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1054\/plef.2001.0341_RF189","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1161\/01.HYP.35.2.679","article-title":"Cardiovascular effects of 2-arachidonoyl glycerol in anesthetized mice","volume":"35","author":"J\u00e1rai","year":"2000","journal-title":"Hypertension"},{"key":"10.1054\/plef.2001.0341_RF190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0090-6980(00)00053-8","article-title":"Oxidative metabolism of anandamide","volume":"61","author":"Burstein","year":"2000","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"10.1054\/plef.2001.0341_RF191","doi-asserted-by":"crossref","first-page":"21181","DOI":"10.1074\/jbc.272.34.21181","article-title":"Synthesis of prostaglandin E2 ethanolamide from anandamide by cyclooxygenase-2","volume":"272","author":"Yu","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1054\/plef.2001.0341_RF192","first-page":"63P","article-title":"Studies on the pharmacology of prostamide F2 \u03b1, a naturally occurring substance","volume":"133","author":"Chen","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF193","first-page":"527","article-title":"Investigation of structural analogs of prostaglandin amides for binding to and activation of CB1 and CB2 cannabinoid receptors in rat brain and human tonsils","author":"Berglund","year":"1999"},{"key":"10.1054\/plef.2001.0341_RF194","series-title":"2001 Symposium on the Cannabinoids","article-title":"Characterisation of the anandamide cyclooxygenase metabolite, PGE2 ethanolamide","author":"Ross","year":"2001"},{"key":"10.1054\/plef.2001.0341_RF195","doi-asserted-by":"crossref","first-page":"33744","DOI":"10.1074\/jbc.M007088200","article-title":"Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2","volume":"275","author":"Kozak","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1054\/plef.2001.0341_RF196","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0005-2760(94)00170-4","article-title":"Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist","volume":"1254","author":"Ueda","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1054\/plef.2001.0341_RF197","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0005-2760(95)00157-8","article-title":"Anandamide hydroxylation by brain lipoxygenase: metabolite structures and potencies at the cannabinoid receptor","volume":"1259","author":"Hampson","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1054\/plef.2001.0341_RF198","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/mol.54.1.180","article-title":"Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation","volume":"54","author":"Edgemond","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF199","doi-asserted-by":"crossref","first-page":"6155","DOI":"10.1073\/pnas.97.11.6155","article-title":"Direct activation of capsaicin receptors by products of lipoxygenases: endogenous capsaicin-like substances","volume":"97","author":"Hwang","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/plef.2001.0341_RF200","doi-asserted-by":"crossref","first-page":"12856","DOI":"10.1074\/jbc.M008555200","article-title":"The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism","volume":"276","author":"De Petrocellis","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1054\/plef.2001.0341_RF201","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.bjp.0704223","article-title":"A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus","volume":"134","author":"Craib","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1054\/plef.2001.0341_RF202","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1523\/JNEUROSCI.19-02-00529.1999","article-title":"Capsaicin binds to the intracellular domain of the capsaicin-activated ion channel","volume":"19","author":"Jung","year":"1999","journal-title":"J Neurosci"},{"key":"10.1054\/plef.2001.0341_RF203","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1021\/bi002303b","article-title":"Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase","volume":"40","author":"Moody","year":"2001","journal-title":"Biochemistry"},{"key":"10.1054\/plef.2001.0341_RF204","doi-asserted-by":"crossref","first-page":"8375","DOI":"10.1073\/pnas.95.14.8375","article-title":"The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation","volume":"95","author":"De Petrocellis","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1054\/plef.2001.0341_RF205","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/73171","article-title":"Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation","volume":"6","author":"Galve-Roperh","year":"2000","journal-title":"Nat Med"},{"key":"10.1054\/plef.2001.0341_RF206","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/archopht.116.11.1433","article-title":"Marijuana smoking vs cannabinoids for glaucoma therapy","volume":"116","author":"Green","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1054\/plef.2001.0341_RF207","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1006\/nbdi.1998.0218","article-title":"Cannabinoid transmission and pain perception","volume":"5","author":"Martin","year":"1998","journal-title":"Neurobiol Dis"},{"key":"10.1054\/plef.2001.0341_RF208","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/89953","article-title":"Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis","volume":"7","author":"B\u00e1tkai","year":"2001","journal-title":"Nat Med"},{"key":"10.1054\/plef.2001.0341_RF209","doi-asserted-by":"crossref","DOI":"10.1016\/S0163-7258(02)00255-3","article-title":"Cannabinoids and multiple sclerosis","author":"Pertwee","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1054\/plef.2001.0341_RF210","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1177\/026988119300700411","article-title":"Effective treatment of Tourette's syndrome with marijuana","volume":"7","author":"Hemming","year":"1993","journal-title":"J Psychopharmacol"},{"key":"10.1054\/plef.2001.0341_RF211","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000057153","article-title":"Cannabis in movement disorders","volume":"6","author":"M\u00fcller-Vahl","year":"1999","journal-title":"Forsch Komplement\u00e4rmed"},{"key":"10.1054\/plef.2001.0341_RF212","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1176\/ajp.156.3.495","article-title":"Treatment of Tourette's syndrome with delta-9-tetrahydrocannabinol","volume":"156","author":"M\u00fcller-Vahl","year":"1999","journal-title":"Am J Psychiatr"}],"container-title":["Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327801903412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952327801903412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T05:42:03Z","timestamp":1682142123000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952327801903412"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,2]]},"references-count":212,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2002,2]]}},"alternative-id":["S0952327801903412"],"URL":"https:\/\/doi.org\/10.1054\/plef.2001.0341","relation":{},"ISSN":["0952-3278"],"issn-type":[{"value":"0952-3278","type":"print"}],"subject":[],"published":{"date-parts":[[2002,2]]}}}